Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
post marketing
Biotech
Biogen to navigate an ethics minefield for post-approval trial
After the Aduhelm approval set a precedent for FDA clearance based on surrogate endpoints, all eyes will be on Biogen's post-approval study.
Amirah Al Idrus
Jun 23, 2021 8:54am
FDA warns Allergan over recalled breast implant safety studies
May 15, 2020 9:45am
FDA warns 2 breast implant makers as safety probe continues
Mar 20, 2019 10:54am
FDA to launch scientific review of implant biocompatibility
Mar 15, 2019 4:54pm
Bayer, FDA extend Essure postmarket safety study by 2 years
Dec 27, 2018 2:20pm
Alcon pulls eye micro-stent from market after new safety data
Aug 30, 2018 7:59am